It is a prescripted oral medicine treatment for the non-small cell lung cancer (NSCLC). After surgery, patients should be given
Alectinib 150 mg tablet as an Adjuvent. It also reduce the chances of cancer spreading (metastasized) to the other parts of the body (brain/CNS). It works by blocking the ALK gene receptor to stop cancer cell growth.
